US

Steven Anthony Rittmanic

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Anthony Rittmanic. Retrieved from https://idiyas.com/inventor/steven-anthony-rittmanic-enfaqmjh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Inventor Spotlight: Steven Anthony Rittmanic

Introduction

Steven Anthony Rittmanic is a notable figure in the realm of innovation, currently contributing his expertise at Next Proteins, Inc. Despite having no patents to his name, Rittmanic plays a pivotal role in the development and application of cutting-edge technologies within his field.

Latest Patents

As of now, Steven Anthony Rittmanic does not hold any patents. However, his work at Next Proteins, Inc. reflects a commitment to pioneering advancements in protein-based solutions.

Career Highlights

Rittmanic's career at Next Proteins, Inc. has been marked by significant contributions to research and development. His dedication to innovation is evident in the projects he has spearheaded, aimed at enhancing the capabilities of protein applications in various industries.

Collaborations

While specific collaborations are not listed, it can be inferred that working at a pioneering company like Next Proteins, Inc. has likely positioned Rittmanic to engage with a network of fellow innovators and researchers, fostering an environment conducive to groundbreaking developments.

Conclusion

In summary, Steven Anthony Rittmanic may not possess patents, but his essential role at Next Proteins, Inc. highlights the importance of innovation and teamwork in driving progress. His ongoing contributions are poised to impact the industry significantly, marking him as an individual to watch in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…